Allergy/Asthma News

Beneath the Surface is a video series in which Joel M. Gelfand, MD, MSCE, Healio Dermatology Chief Medical Editor, discusses hot topics in the field with leading experts.

Physicians can use social media to combat medical misinformation that spreads through it, according to a speaker at the Osteopathic Medical Education Conference.

As a dentist, I believe it is crucial to highlight the growing evidence linking periodontal health with systemic conditions, particularly respiratory diseases.

Children diagnosed with atopic dermatitis or food allergy were more likely to develop either disorder as time went on, according to a study published in Pediatric Allergy and Immunology.

The validated food allergy severity score was useful in classifying the severity of reactions among patients with allergies to various fish, according to a letter published in Annals of Allergy, Asthma & Immunology.

Time in the market is far more important than timing the market. Long-term investors will utilize both the strategies of dollar cost averaging and lump sum investing to reach their investment goals.

Organon and Dermavant have entered a definitive agreement in which Organon will acquire Dermavant, according to a press release.

The FDA approved AstraZeneca’s Fasenra for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis, or EGPA, according to a company press release.

Patients who have frequent asthma exacerbations are at greater risks for cumulative doses of corticosteroids, multiple comorbidities and mortality, according to a poster presented at the European Respiratory Society International Congress.

The FDA has missed its action date to address its proposed rule banning formaldehyde and formaldehyde-releasing chemicals from hair smoothing and straightening products.